Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Sees Path To Rx Benefit In 2002; Wants “Clean” PDUFA Renewal

Executive Summary

The Pharmaceutical Research & Manufacturers of America sees a path to enactment of a Medicare prescription drug benefit in 2002

You may also be interested in...



HHS Urges PhRMA To Seek Accord With Pharmacy On Universal Card

Brand-name manufacturers should join with retail pharmacists to create a universal prescription drug discount card, HHS Secretary Tommy Thompson told the Pharmaceutical Research & Manufacturers of America annual meeting March 23 in Palm Beach, Fla

HHS Urges PhRMA To Seek Accord With Pharmacy On Universal Card

Brand-name manufacturers should join with retail pharmacists to create a universal prescription drug discount card, HHS Secretary Tommy Thompson told the Pharmaceutical Research & Manufacturers of America annual meeting March 23 in Palm Beach, Fla

BIO Wants More Binding FDA/Sponsor Meetings As Part Of PDUFA III

The Biotechnology Industry Organization is seeking to use PDUFA reform to write a requirement into FDA's legislative mandate for more binding consultations between BLA sponsors and FDA staff before the actual application review begins

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039231

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel